Recursion Pharmaceuticals
RXRX
#4202
Rank
C$2.79 B
Marketcap
$6.94
Share price
-6.59%
Change (1 day)
-41.66%
Change (1 year)

EPS for Recursion Pharmaceuticals (RXRX)

EPS in 2023 (TTM): -$1.86

According to Recursion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.94. In 2022 the company made an earnings per share (EPS) of -$1.92 a decrease over its 2021 EPS that were of -$1.64.

EPS history for Recursion Pharmaceuticals from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.86-3.21%
2022-$1.9217.39%
2021-$1.6450.85%
2020-$1.09